Skip to content

A Pilot Study of Topical honey for the treatment of Cold Sores

In adult patients with cold sores is topical medical-grade honey acceptable and as good as or better than aciclovir for reducing the healing time?

Status
Completed
Phases
Unknown
Study type
Interventional
Source
ANZCTR
Registry ID
ACTRN12612000564853
Enrollment
15
Registered
2012-05-25
Start date
2012-06-30
Completion date
2012-09-12
Last updated
2020-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Brief summary

There are reasons to believe that medical grade-honey applied directly to skin may be an effective treatment for cold sores. In this study 15 adults with recurrent cold sores will take part in a cross-over study comparing medical grade honey and topical aciclovir for the treatment of cold sores When participants develop a cold sore they will start using the first allocated treatment on it for the duration of the lesion (maximum 2 weeks) and complete a subject diary. When participants develop a second cold sore they will use the second allocated treatment for the duration of the lesion (maximum 2 weeks) and complete a subject diary. The sequesnce of honey then aciclovir or aciclovir then honey will be allocated randomly. This trial will provide useful information on the practicalities of topical honey as a treatment for eczema. It will also give an initial signal as to whether honey may be effective.

Interventions

Topical medical grade honey applied to lesion with an amount sufficient to cover the lesion in a thin film for 15mins, five times per day

Sponsors

Medical Research Institute of New Zealand
Lead SponsorCharities/Societies/Foundations

Study design

Allocation
Randomised controlled trial
Primary purpose
Treatment

Eligibility

Sex/Gender
All
Age
16 Years to No maximum
Healthy volunteers
No

Inclusion criteria

Aged 16 or over at the time of enrolment At least two episodes of cold sores in the past 12 months

Exclusion criteria

Known immune suppression or receiving medication likely to cause immune suppression Requirement for systemic antiviral or antibiotic therapy, as judged by treating doctor Known or suspected allergy to honey or acyclovir Any other condition which, at the investigators discretion, it is believed may present a safety risk or impact the feasibility of the study or the study results

Outcome results

None listed

Source: ANZCTR · Data processed: Feb 4, 2026